COWEN AND COMPANY, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$24,084,510
-45.1%
2,338,302
-12.2%
1.68%
-53.7%
Q2 2023$43,903,972
+28.4%
2,664,076
-28.6%
3.64%
-9.4%
Q1 2023$34,192,246
+27.9%
3,732,7780.0%4.02%
+43.7%
Q4 2022$26,726,690
+42.9%
3,732,7780.0%2.79%
+56.2%
Q3 2022$18,701,000
+105.3%
3,732,7780.0%1.79%
+103.3%
Q2 2022$9,108,000
-64.3%
3,732,7780.0%0.88%
-64.1%
Q1 2022$25,495,000
-15.5%
3,732,7780.0%2.45%
-10.3%
Q4 2021$30,161,000
+21.9%
3,732,778
+47.8%
2.74%
+133.2%
Q3 2021$24,749,000
+47.4%
2,525,452
+1.2%
1.17%
+33.8%
Q2 2021$16,795,000
-25.6%
2,495,5730.0%0.88%
-43.5%
Q1 2021$22,560,000
+78.5%
2,495,573
+31.9%
1.55%
+37.4%
Q4 2020$12,639,000
+31.6%
1,892,043
-0.7%
1.13%
-28.0%
Q3 2020$9,606,000
-37.7%
1,905,990
-0.1%
1.57%
-38.8%
Q2 2020$15,413,000
+43.2%
1,907,504
+25.7%
2.56%
+3.6%
Q1 2020$10,767,0001,517,2962.47%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,498,838$22,889,35511.72%
Knoll Capital Management, LLC 500,000$4,580,0007.06%
GENDELL JEFFREY L 5,301,914$48,565,5324.55%
COWEN AND COMPANY, LLC 3,732,778$34,192,2464.02%
Tri Locum Partners LP 1,327,097$12,156,2093.70%
Samsara BioCapital, LLC 1,409,409$12,910,1862.67%
Altium Capital Management LP 500,000$4,580,0002.54%
Vivo Capital, LLC 3,761,438$34,454,7722.39%
RTW INVESTMENTS, LP 5,741,939$52,596,1611.10%
Knott David M Jr 291,113$2,6671.05%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders